Stocks and Investing Stocks and Investing
Tue, October 1, 2024

Raghuram Selvaraju Reiterated (VRNA) at Strong Buy and Held Target at $36 on, Oct 1st, 2024


Published on 2024-10-28 14:33:42 - WOPRAI, Raghuram Selvaraju
  Print publication without navigation


Raghuram Selvaraju of HC Wainwright & Co., Reiterated "Verona Pharma plc" (VRNA) at Strong Buy and Held Target at $36 on, Oct 1st, 2024.

Raghuram has made no other calls on VRNA in the last 4 months.



There are 2 other peers that have a rating on VRNA. Out of the 2 peers that are also analyzing VRNA, 0 agree with Raghuram's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Raghuram


  • Edward Nash of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $37 on, Monday, July 22nd, 2024
  • Joon Lee of "Truist Securities" Maintained at Strong Buy with Increased Target to $38 on, Friday, June 28th, 2024

Contributing Sources
    D885FD0B-4D59-419D-81DE-3DF4BF5AB503
  • support@woprai.com